Del. Court Won't Pause 'Orange Book' Delisting

A Delaware federal court on Monday refused to pause an order requiring Jazz Pharmaceuticals to remove a patent for a narcolepsy drug from health regulators' listing of approved drugs, but the...

Already a subscriber? Click here to view full article